Insider · CIK 0001352546

Flynn James E

Reports to the SEC for 91 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001352546

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	NUVLNuvalent, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−43K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc.U Disposition from Tender	Director, 10% Owner, Director by Deputization	UDisposition from Tender	−5,146 sh	$124.00	−$638K	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−20K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−3,789 sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−3,789 sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−4,147 sh	—	—	0
2026-07-15	NUVLNuvalent, Inc.D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−650K sh	$124.00	−$80.6M	0
2026-07-15	NUVLNuvalent, Inc.D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−8.3M sh	$124.00	−$1.03B	0
2026-07-15	NUVLNuvalent, Inc.D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−3,444 sh	$124.00	−$427K	0
2026-07-15	NUVLNuvalent, Inc.D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−8.3M sh	$124.00	−$1.03B	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−43K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−15K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−4,147 sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−15K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Class B Common StockD Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−2.72M sh	$124.00	−$337M	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−20K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc.U Disposition from Tender	Director, 10% Owner, Director by Deputization	UDisposition from Tender	−5,146 sh	$124.00	−$638K	0
2026-07-15	NUVLNuvalent, Inc. · Class B Common StockD Disposition to Issuer	Director, 10% Owner, Director by Deputization	DDisposition to Issuer	−2.72M sh	$124.00	−$337M	0
2026-06-16	NUVLNuvalent, Inc.A Award	Director, 10% Owner, Director by Deputization	AAward	+3,444 sh	—	—	3,444
2026-06-11	PBLSParabilis Medicines, Inc. · Series A Preferred StockC Conversion	10% Owner, Possible Member of 10% Group	CConversion	−166K sh	—	—	0
2026-06-11	PBLSParabilis Medicines, Inc. · Series B Preferred StockC Conversion	10% Owner, Possible Member of 10% Group	CConversion	−144K sh	—	—	0
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	10% Owner, Possible Member of 10% Group	CConversion	+407K sh	—	—	940,352
2026-06-11	PBLSParabilis Medicines, Inc. · Series B Preferred StockC Conversion	10% Owner, Possible Member of 10% Group	CConversion	−144K sh	—	—	0
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	10% Owner, Possible Member of 10% Group	CConversion	+123K sh	—	—	122,990
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	10% Owner, Possible Member of 10% Group	CConversion	+149K sh	—	—	272,228
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	10% Owner, Possible Member of 10% Group	CConversion	+261K sh	—	—	533,220
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	10% Owner, Possible Member of 10% Group	CConversion	+407K sh	—	—	940,352
2026-06-11	PBLSParabilis Medicines, Inc. · Series D Preferred StockC Conversion	10% Owner, Possible Member of 10% Group	CConversion	−465K sh	—	—	0
2026-06-11	PBLSParabilis Medicines, Inc. · Series C Preferred StockC Conversion	10% Owner, Possible Member of 10% Group	CConversion	−247K sh	—	—	0
2026-06-11	PBLSParabilis Medicines, Inc. · Series A Preferred StockC Conversion	10% Owner, Possible Member of 10% Group	CConversion	−166K sh	—	—	0
2026-06-11	PBLSParabilis Medicines, Inc. · Series D Preferred StockC Conversion	10% Owner, Possible Member of 10% Group	CConversion	−465K sh	—	—	0
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	10% Owner, Possible Member of 10% Group	CConversion	+261K sh	—	—	533,220
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	10% Owner, Possible Member of 10% Group	CConversion	+149K sh	—	—	272,228
2026-06-11	PBLSParabilis Medicines, Inc. · Series C Preferred StockC Conversion	10% Owner, Possible Member of 10% Group	CConversion	−247K sh	—	—	0
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	10% Owner, Possible Member of 10% Group	CConversion	+123K sh	—	—	122,990
2026-05-19	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner, * Director by Deputization	AAward	+55.2K sh	—	—	55,150
2026-02-27	LRMRLarimar Therapeutics, Inc.P Purchase	Director, 10% Owner, * Director by Deputization	PPurchase	+832K sh	$5.00	+$4.16M	8,153,107
2026-02-27	LRMRLarimar Therapeutics, Inc.P Purchase	Director, 10% Owner, * Director by Deputization	PPurchase	+1.08M sh	$5.00	+$5.42M	10,622,928
2026-02-27	LRMRLarimar Therapeutics, Inc.P Purchase	Director, 10% Owner, * Director by Deputization	PPurchase	+2M sh	$5.00	+$10M	6,207,982
2026-02-27	LRMRLarimar Therapeutics, Inc.P Purchase	Director, 10% Owner, * Director by Deputization	PPurchase	+1.08M sh	$5.00	+$5.42M	10,622,957
2025-11-24	NUVLNuvalent, Inc.S Sale	Director, 10% Owner, Director by Deputization	SSale	−371K sh	$95.44	−$35.4M	8,299,225
2025-11-24	NUVLNuvalent, Inc.S Sale	Director, 10% Owner, Director by Deputization	SSale	−371K sh	$95.44	−$35.4M	8,299,225
2025-07-31	LRMRLarimar Therapeutics, Inc.P Purchase	Director, 10% Owner, * Director by Deputization	PPurchase	+3.39M sh	$3.20	+$10.8M	9,538,945
2025-07-31	LRMRLarimar Therapeutics, Inc.P Purchase	Director, 10% Owner, * Director by Deputization	PPurchase	+2.6M sh	$3.20	+$8.32M	7,321,129
2025-07-31	LRMRLarimar Therapeutics, Inc.P Purchase	Director, 10% Owner, * Director by Deputization	PPurchase	+3.39M sh	$3.20	+$10.8M	9,538,918
2025-06-27	SPRYARS Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−370K sh	$18.46	−$6.83M	4,887,254
2025-06-27	SPRYARS Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−370K sh	$18.46	−$6.83M	4,887,254
2025-06-18	NUVLNuvalent, Inc.A Award	Director, 10% Owner, Director by Deputization	AAward	+2,647 sh	—	—	2,647
2025-06-18	NUVLNuvalent, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner, Director by Deputization	AAward	+4,147 sh	—	—	4,147
2025-06-18	NUVLNuvalent, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner, Director by Deputization	AAward	+4,147 sh	—	—	4,147

Recent filings

Accepted (ET)
Jul 174
DEERFIELD MANAGEMENT COMPANY, L.P.0001193805-26-000978
SEC(opens sec.gov)
Jun 184
DEERFIELD MANAGEMENT COMPANY, L.P.0001193805-26-000845
SEC(opens sec.gov)
Jun 114
DEERFIELD MANAGEMENT COMPANY, L.P.0001193805-26-000798
SEC(opens sec.gov)

Companies

Address

345 PARK AVENUE SOUTH, 12TH FLOOR

NEW YORK, NY, 10010